2. Search Result
Search Result
Results for "

Ceftazidime

" in MedChemExpress (MCE) Product Catalog:

18

Inhibitors & Agonists

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0593
    Ceftazidime
    20+ Cited Publications

    GR20263

    		 Beta-lactamase Bacterial Antibiotic Infection
    Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases .
    Ceftazidime
  • HY-B0593A
    Ceftazidime pentahydrate
    20+ Cited Publications

    GR20263 pentahydrate

    		 Beta-lactamase Bacterial Antibiotic Infection Cancer
    Ceftazidime (GR20263) pentahydrate , an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime pentahydrate is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases .
    Ceftazidime pentahydrate
  • HY-B0593R
    Ceftazidime (Standard)

    		Beta-lactamase Bacterial Antibiotic Infection
    Ceftazidime (Standard) is the analytical standard of Ceftazidime. This product is intended for research and analytical applications. Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases .
    Ceftazidime (Standard)
  • HY-B0593AR
    Ceftazidime pentahydrate (Standard)

    		Beta-lactamase Bacterial Antibiotic Infection Cancer
    Ceftazidime (pentahydrate) (Standard) is the analytical standard of Ceftazidime (pentahydrate). This product is intended for research and analytical applications. Ceftazidime (GR20263) pentahydrate , an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime pentahydrate is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases .
    Ceftazidime pentahydrate (Standard)
  • HY-B0593S
    Ceftazidime-d5

    GR20263-d5

    		 Isotope-Labeled Compounds Others
    Ceftazidime-d5 is the deuterium labeled Ceftazidime. Radioactive isotopes labeled compounds can be used in metabolic analysis, allowing the movement of individual atoms to be precisely tracked and quantified .
    Ceftazidime-d5
  • HY-139777
    Antibacterial agent 60

    		Bacterial Infection
    Antibacterial agent 60, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 60
  • HY-139775
    Antibacterial agent 58

    		Bacterial Infection
    Antibacterial agent 58, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 58
  • HY-139765
    Antibacterial agent 48

    		Bacterial Infection
    Antibacterial agent 48, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 48
  • HY-139764
    Antibacterial agent 47

    		Bacterial Infection
    Antibacterial agent 47, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 47
  • HY-139762
    Antibacterial agent 45

    		Bacterial Infection
    Antibacterial agent 45, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 45
  • HY-139759
    Antibacterial agent 42

    		Bacterial Infection
    Antibacterial agent 42, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 42
  • HY-139756
    Antibacterial agent 39

    		Bacterial Infection
    Antibacterial agent 39, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 39
  • HY-139752
    Antibacterial agent 35

    		Bacterial Infection
    Antibacterial agent 35, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 35
  • HY-139750
    Antibacterial agent 34

    		Bacterial Infection
    Antibacterial agent 35, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 34
  • HY-139749
    Antibacterial agent 33

    		Bacterial Cancer
    Antibacterial agent 33, an antibacterial agent, significantly lowers MIC value of antibacterial agent Ceftazidime .
    Antibacterial agent 33
  • HY-14879D
    ent-Avibactam sodium

    AVE1330A

    		 Others Infection
    ent-Avibactam sodium (AVE1330A) is a new β-lactamase inhibitor with broad-spectrum antibacterial activity. ent-Avibactam sodium, in combination with ceftazidime, exhibits significant inhibitory effects on Enterobacteriaceae that produce Ambler class A and class C beta-lactamases. The IC50 value of ent-Avibactam sodium is much lower than the commonly used β-lactamase inhibitors clavulanic acid and ticarbonitrile, showing its ability to inhibit TEM-1 and P99 enzyme efficiency .
    ent-Avibactam sodium
  • HY-117736
    Ro 09-1428

    		Penicillin-binding protein (PBP) Bacterial Infection Inflammation/Immunology
    Ro 09-1428 is a broad-spectrum parenteral cephalosporin. Ro 09-1428 has potent antibacterial activities against Pseudomonas aeruginosa and Acinetobacter caloaceticus, with MIC90s of 0.39 and 6.25 μg/mL, respectively, better than Ceftazidime (HY-B0593). Additionally, Ro 09-1428 shows high activity against Escherichia coli, Kkbsielia pneumoniae, Proteus mirabilis, P. aeruginosa, staphylococci, and more. Ro 09-1428 preferentially attacks PBP 3 for target in E. coli and P. aeruginosa, which is promising for research of septicemias and serious P. aeruginosa infections .
    Ro 09-1428
  • HY-113703
    PD117588

    		Others Cancer
    PD117588 is a quinolone antibacterial agent with a broad range of antibacterial activity. PD117588 exhibits excellent activity against a variety of Gram-positive and Gram-negative bacteria from cancer patients, especially against all Gram-positive strains, including methicillin-resistant Staphylococcus aureus, coagulase-negative Staphylococci, and Enterococci. PD117588 is also very effective against most Gram-negative bacilli, although ciprofloxacin shows stronger activity against Pseudomonas aeruginosa. Compared with other quinolone antibiotics, the minimum inhibitory concentration of PD117588 outperforms most of the tested microorganisms, including imipenem and ceftazidime .
    PD117588

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: